Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease Geoffrey M. Graeber, MD*, Naresh.

Slides:

Advertisements

Similar presentations

CT and PET imaging in non-small cell lung cancer

Advertisements

Evaluation of 18F-FDG PET-CT for Differentiation of Pulmonary Pathology in an Approach of Outpatient Fast Track Assessment Tjeerd S. Aukema, MD, Renato.

Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications

Michael Lin, Jenn Hian Koo, David Abi–Hanna

PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma Kemp H Kernstine, MD, PhD, William Stanford, MD, Brian F Mullan,

FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies Marcelo F.K. Benveniste, MD, Cesar A.

PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,

[18F] 3-deoxy-3′-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-d-glucose positron emission.

Ugonna N. Ihekweazu, BS, William D. Travis, MD, Raja M. Flores, MD

Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography Walter.

Hiren J. Mehta, MD, Tan-Lucien Mohammed, MD, Michael A. Jantz, MD

Positron Emission Tomography in Lung Cancer

Diffusion-weighted magnetic resonance imaging in preoperative assessment of non– small cell lung cancer Hiroaki Nomori, MD, Yue Cong, MD, Masaru Abe,

Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer Ernest Nadal,

Volume 4, Issue 3, Pages (April 2018)

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

A follow-up of integrated positron emission tomography/computed tomography after curative resection of non–small-cell lung cancer in asymptomatic patients

Future of Thoracic PET Scanning

Detection of extrathoracic metastases by positron emission tomography in lung cancer Walter Weder, MD, Ralph A Schmid, MD, Helke Bruchhaus, MD, Sven Hillinger,

Volume 1, Issue 3, Pages (May 2015)

Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.

Carmel G. Cronin, Michael Moore, Michael A. Blake

Paraneoplastic Limbic Encephalitis and Small-Cell Lung Carcinoma

Transesophageal biopsy of mediastinal and pulmonary tumors by means of endoscopic ultrasound guidance Michael Hünerbein, MD, Bijan Michael Ghadimi, MD,

MET-Mutated NSCLC with Major Response to Crizotinib

Sarcoid-Like Reaction Mimics Progression of Disease After Induction Chemotherapy for Lung Cancer Masayuki Chida, MD, PhD, Takashi Inoue, MD, Koichi Honma,

Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,

The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients.

Future of Thoracic PET Scanning

Video-Assisted Mediastinoscopic Lymphadenectomy for Staging Non-Small Cell Lung Cancer Sergi Call, MD, Carme Obiols, MD, PhD, Ramon Rami-Porta, MD, PhD,

Unexpected Small Bowel Intussusception Caused by Lung Cancer Metastasis on 18F- Fluorodeoxyglucose PET-CT Jeong Won Lee, MD, Seok-Ki Kim, MD, Ji Won Park,

Misdiagnosis of a Small Cell Lung Cancer Resulting From Inaccurate Pathology Tie-niu Song, MD, Jian-hua Zhang, MD, PhD, Bin Li, PhD, Hui Zhou, BA, Peng.

Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations Lynette M. Sholl, MD, Mizuki Nishino, MD, Saraswati.

Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer

Are We Missing Diagnosis of Large Vessel Vasculitis

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer Hiroyasu Kaneda, MD, PhD, Isamu.

Clinical-pathologic conference in general thoracic surgery: metastatic placental site trophoblastic tumor G.Alexander Patterson, MD The Journal of Thoracic.

Volume 140, Issue 1, Pages (July 2011)

Robert J. Korst, MD, Michael E. Burt, MD, PhD

Atypical Pleuropulmonary Tuberculosis Mimicking a Malignant Disease

Role of Positron Emission Tomography in Staging Esophageal Cancer

The impact of 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: Results from Westmead Hospital, Sydney, Australia Rebecca.

Primary pulmonary meningioma: Ten-year follow-up findings for a multiple case, implying a benign biological nature Yukitoshi Satoh, Yuichi Ishikawa

Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD

Gilbert Massard, MD, Jean-Marie Wihlm, MD, Georges Morand, MD

Lorenzo Spaggiari, MD, PhD, Ugo Pastorino, MD

Metastasectomy in a lung graft using high-flow venovenous extracorporeal lung support in a patient after single lung transplantation Bassam Redwan, MD,

The role of positron emission tomography for non-small cell lung cancer Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD Practical.

Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.

The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer P. Flamen, MD, A. Lerut, MD, PhD, E. Van Cutsem,

Pulmonary Metastases from Cervical Adenocarcinoma Regress to a ‘Hole’ Lot of Nothing Michael Guandalini, MBBS (Hons), BPhty, Karin Steinke, MD, MS, PD,

Acute intramural hematoma of the aorta as a cause of positive fluorodeoxyglucose positron emission tomography/computed tomography Alex Ryan, MD, Barry.

A Case of Nontuberculous Mycobacteria Highly Suspected as Lung Cancer Invading the Aortic Arch Tadashi Umehara, MD, Masaya Aoki, MD, PhD, Aya Harada,

Detection of an Asymptomatic Right-Ventricle Cardiac Metastasis from a Small-Cell Lung Cancer by F-18-FDG PET/CT Maria Victoria Orcurto, MD, Angelika.

Insidious: Takayasu Arteritis

Matthew Reichert, MD, Eric S. Bensadoun, MD

Multiple Primary Cancers or Multiple Metastases, That Is the Question

Nicholas W. Choong, MD, Robert S. Hellman, MD

Marianna Koczywas, MD, Mihaela C. Cristea, MD

Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Kemp H Kernstine, MD, PhD, Kelley A McLaughlin,

Metastatic Lung Cancer to the Pancreas

Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer Catherine A.B Saunders, Julian.

CT (left of images) showing calcified areas and PET (right of images) scans showing increased FDG-PET metabolic activity in the mediastinal mass (A) and.

FDG imaging of a pulmonary artery sarcoma

The clinical stage of non–small cell lung cancer as assessed by means of fluorodeoxyglucose–positron emission tomographic/computed tomographic scanning.

Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy Matthew S. Block, MD, PhD, Robert Vassallo,

Awais Ashfaq, MD, Holenarasipur R. Vikram, MD, Janis E

Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States Megan E. Daly, MD, Julian R.

Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography Kwhanmien Kim, MD, Seung Joon Park,

Figure 12a Pitfalls in N staging at CT and PET

Presentation transcript:

Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease Geoffrey M. Graeber, MD*, Naresh C. Gupta, MD**, Gordon F. Murray, MD*** The Journal of Thoracic and Cardiovascular Surgery Volume 117, Issue 4, Pages 719-727 (April 1999) DOI: 10.1016/S0022-5223(99)70292-8 Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 1 A PET-FDG imaging study (coronal view) demonstrating intense FDG uptake in the hilar area of the right lung in a patient with a primary lung cancer. There are also focal areas of enhanced uptake consistent with metastatic lymph nodes in the right infrahilar and left perihilar regions. The Journal of Thoracic and Cardiovascular Surgery 1999 117, 719-727DOI: (10.1016/S0022-5223(99)70292-8) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 2 The plates presented in this figure demonstrate the utility of collecting PET images in multiple projections. A, A selected cut from a chest CT scan taken in a 62-year-old woman who had a primary pulmonary malignant tumor at the hilum of the left lung. B, A selected coronal image in the same patient shows a prominent left hilar carcinoma just above the area of intensity generated by the ventricular myocardium. A metastatic nodule is apparent in the right paratracheal region near the head of the clavicle. The area of intense activity low in the projection represents residual metabolized FDG present in the patient's urinary bladder. C, This parasagittal view in the same patient shows part of the metabolic activity recorded from PET-FDG in the heart and bladder, as well as the metastatic nodes in the superior mediastinum. Most important, it detected a metastatic bone lesion that was a previously unsuspected metastasis in the spine, seen at the far right of the image. The Journal of Thoracic and Cardiovascular Surgery 1999 117, 719-727DOI: (10.1016/S0022-5223(99)70292-8) Copyright © 1999 Mosby, Inc. Terms and Conditions